Publication:
Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis B

Simple item page
dc.contributor.authorPatrick, Marcellin
dc.contributor.authorFerruccio, Bonino
dc.contributor.authorLau, Grace
dc.contributor.authorPatrizia, Farci
dc.contributor.authorYurdaydın, Cihan
dc.contributor.authorPiratvisuth, Teerha
dc.contributor.authorJin, Rui
dc.contributor.authorHadziyannis, Stephanos
dc.contributor.authorLu, Zhi-Meng
dc.contributor.authorPopescu, Matei
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentGastroenteroloji Ana Bilim Dalı
dc.date.accessioned2022-03-11T07:50:53Z
dc.date.available2022-03-11T07:50:53Z
dc.date.issued2005-10
dc.descriptionBu çalışma, 11-15 Kasım 2005 tarihleri arasında San Francisco[Californiya]’da düzenlenen 56. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Assoc Study Liver Dis
dc.identifier.citationMarcellin, P. vd. (2005). "Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis B". Hepatology, 42(4), Supplement 1, 580A-580A.
dc.identifier.endpage580A
dc.identifier.issn0270-9139
dc.identifier.issue4
dc.identifier.startpage580A
dc.identifier.urihttp://hdl.handle.net/11452/24946
dc.identifier.volume42
dc.identifier.wos000232480302034
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherWiley
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastroenterology & hepatology
dc.subject.wosGastroenterology & hepatology
dc.titleFactors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis B
dc.typeMeeting Abstract
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Gastroenteroloji Ana Bilim Dalı
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications